Literature DB >> 22179769

[Diagnosing neurovascular compression syndromes].

S Langner1, H W Schroeder, N Hosten, M Kirsch.   

Abstract

PURPOSE: Neurovascular compression syndromes are diseases caused by abnormal contact between a vessel loop and the root exit/entry zone of a cranial nerve. Compression can cause paroxysmal attacks of abnormal motor or sensory phenomena in the affected nerve.
MATERIALS AND METHODS: Review based on a selective analysis of the literature.
RESULTS: Neurovascular compression syndromes include well-established entities such as trigeminal neuralgia, facial hemispasm, vestibular paroxysmia and glossopharyngeus neuralgia but also cranial nerve disorders caused by compression due to an aneurysm, e. g., oculomotor nerve paresis caused by an aneurysm of the posterior communicating branch. An overview of neurovascular compression syndromes is given, outlining diagnostic procedures and the morphological imaging features of each syndrome as well as the changes seen after treatment are described.
CONCLUSION: Neurovascular compression syndromes are complex diseases. MR imaging plays an important role in the diagnostic workup of these diseases. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22179769     DOI: 10.1055/s-0031-1281976

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

1.  Analysis of morphologic and hemodynamic parameters for unruptured posterior communicating artery aneurysms with oculomotor nerve palsy.

Authors:  Y Yu; J Xu; Y Fang; X Wu; P Yang; C Jiang; Y Qian; J Liu; Q Huang
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

Review 2.  Disorders of the lower cranial nerves.

Authors:  Josef Finsterer; Wolfgang Grisold
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

3.  Hemodynamic and Morphological Analysis of Mirror Aneurysms Prior to Rupture.

Authors:  Jinlong Yuan; Chenlei Huang; Niansheng Lai; Zhenbao Li; Xiaochun Jiang; Xuanzhi Wang; Xintong Zhao; Degang Wu; Jiaqiang Liu; Dayong Xia; Xinggen Fang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-27       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.